1. Home
  2. RRC vs CORT Comparison

RRC vs CORT Comparison

Compare RRC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Range Resources Corporation

RRC

Range Resources Corporation

N/A

Current Price

$41.21

Market Cap

9.8B

Sector

Energy

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$112.12

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RRC
CORT
Founded
1976
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
9.7B
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
RRC
CORT
Price
$41.21
$112.12
Analyst Decision
Hold
Buy
Analyst Count
18
5
Target Price
$43.67
$96.50
AVG Volume (30 Days)
2.0M
724.5K
Earning Date
04-21-2026
04-30-2026
Dividend Yield
0.92%
N/A
EPS Growth
151.38
N/A
EPS
2.27
0.09
Revenue
$3,115,515,000.00
$761,407,000.00
Revenue This Year
$15.60
$26.08
Revenue Next Year
$9.73
$26.98
P/E Ratio
$18.13
$1,253.22
Revenue Growth
28.90
12.79
52 Week Low
$32.68
$28.66
52 Week High
$48.31
$126.38

Technical Indicators

Market Signals
Indicator
RRC
CORT
Relative Strength Index (RSI) 56.50 52.12
Support Level $40.16 $77.73
Resistance Level $43.19 $124.30
Average True Range (ATR) 0.98 4.69
MACD -0.13 -1.14
Stochastic Oscillator 52.69 29.75

Price Performance

Historical Comparison
RRC
CORT

About RRC Range Resources Corporation

Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: